Researchers explain why decaying SARS-CoV-2 antibodies in blood are not a problem after vaccination
A new study published in the preprint bioRxiv* server suggests vaccination helps to inflate the number of somatic hypermutations acquired by B cells. The increase in somatic hypermutations allows for an accumulation of highly matured bone marrow plasma cells.
Oral SARS-CoV-2 Mpro inhibitor for therapeutic use
A new study describes a new small molecule compound that has shown impressive safety, tolerability, and bioavailability against SARS-CoV-2.
Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants
A recent study assesses the boost in antibodies against SARS-CoV-2)variants post-vaccination in plasma samples from previously infected COVID-19 patients.
Drinking alcohol and not exercising are modifiable risk factors for SARS-CoV-2
New research from the United Kingdom suggests several factors that increased the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection involved higher alcohol use, Asian/Asian British ethnicity, and obesity. In addition, moderate but not vigorous exercise of more than 10 hours a week was associated with lower susceptibility to infection.
COVID-19: The older you are, the more antibodies you have, study finds
Chemists looked at lab samples of patients who recovered from a mild case of COVID-19 and found that those over 50 produced more antibodies against the SARS-CoV-2 virus.
Increase in SARS-CoV-2 seroprevalence in Irish HCWs during third wave of pandemic
Healthcare workers and people they live with are at an increased risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Hospital healthcare workers (HCWs) worldwide have been found to have a higher number of SARS-CoV-2 infections and higher antibody seroprevalence compared to the general population.
New data points to major SARS-CoV-2 animal reservoir in deer in Iowa
A new study tests the hypothesis that white-tailed deer are susceptible to SARS-CoV-2 infection.
Fast evolution of SARS-CoV-2 driven by extensive RNA deamination by host cells
A new study proposed that the RNA structure and the genome component may serve as an important basis of different deamination spectrums in SARS-CoV-2.
World News | Pfizer, AstraZeneca Covid Vaccines Generate More Antibodies Than Natural Infection: Study
Get latest articles and stories on World at LatestLY. People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study published in Scientific Reports journal on Monday. World News | Pfizer, AstraZeneca Covid Vaccines Generate More Antibodies Than Natural Infection: Study.
The older you are, the more antibodies you have: Study
Science News: WASHINGTON: With the emergence of SARS-CoV-2 variants worldwide, the pandemic's spread is accelerating.
Pfizer, Astra shots generate more antibodies than natural infection: Study
People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study
‘Pfizer, AstraZeneca vax generate more antibodies than natural infection’
People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study published in Scientific Reports journal on Monday.
CDC study shows COVID-19 in newborns is rare
To date, there have been relatively few cases of neonates with COVID-19, and there is limited knowledge of neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, recent studies have suggested an increased risk of severe COVID-19 in infants compared to older children, which is based on data that shows an increased rate of hospitalization among infants.
Half of US Covid vax hesitant unlikely to change their mind: Survey
Half of those in the US who are unwilling to be vaccinated against SARS-CoV-2 report that nothing will change their mind, says a new survey.
Half of US Covid vax hesitant unlikely to change their mind: Survey
New York, Nov 7 : Half of those in the US who are unwilling to be vaccinated against SARS-CoV-2 report that nothing will change their mind, says a new survey. The survey found that 21.4 per cent of participants from across the US were unwilling to be vaccinated against SARS-CoV-2, with 19.7 per cent in Dallas, […]
Pfizer’s COVID-19 pill cuts hospitalization or death by nearly 90%
Pfizer’s experimental antiviral pill, developed to inhibit the replication of SARS-CoV-2 and prevent severe COVID-19, has shown extraordinary efficacy in the first data from a large Phase 2/3 clinical trial. The results, yet to be published in a peer-reviewed journal, reveal the new oral treatment reduces hospitalization or death in high-risk patients by 89 percent compared to placebo.
Hemin as a potential therapy for COVID-19
The current study explores the antiviral activity of HO-1 induced by hemin against SARS-CoV-2 and attempts to describe the mechanism of its anti-viral action.
Half of US Covid vax hesitant unlikely to change their mind: Survey
New York: Half of those in the US who are unwilling to be vaccinated against SARS-CoV-2 report that nothing will change their mind, says a new survey. The
last updated on 9 Nov 11:44